2012
DOI: 10.1016/j.ijpharm.2012.09.019
|View full text |Cite
|
Sign up to set email alerts
|

Porous core/sheath composite nanofibers fabricated by coaxial electrospinning as a potential mat for drug release system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
83
0
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 174 publications
(89 citation statements)
references
References 43 publications
4
83
0
2
Order By: Relevance
“…Basic science in tissue engineering and regenerative medicine aims to investigate and understand the deposition, growth, and remodeling of tissues by exploiting the knowledge and experiences from a range of disciplines (Nguyen et al, 2012;Xue et al, 2014).…”
Section: Nanofibers In Tissue Regenerationmentioning
confidence: 99%
“…Basic science in tissue engineering and regenerative medicine aims to investigate and understand the deposition, growth, and remodeling of tissues by exploiting the knowledge and experiences from a range of disciplines (Nguyen et al, 2012;Xue et al, 2014).…”
Section: Nanofibers In Tissue Regenerationmentioning
confidence: 99%
“…Fibers can be collected on a stationary collector for nonwoven fiber structure or on a rotating mandrel for aligned fiber structure [62]. Fibers can be produced by a coaxial or even triaxial nozzle to enable the core-shell structure [63,64]. Others demonstrated the possibility of pharmaceutical scaleup during the production of fiber mesh [65].…”
Section: Nanoparticles/micelles/lipidsmentioning
confidence: 99%
“…The solubility of the carrier and the availability of the drug to the dissolution medium can be tailored via coaxial electrospinning. The drug release rate was found to increase with an increasing core flow rate due to the presence of a high amount of water-soluble polymer (e.g., PEG) in the cores of the tested fibres (Nguyen et al, 2012) when an insoluble polymer (e.g., PLA) was applied as the sheath fluid. In addition to the use of carriers of different solubilities, the drug release rate can be controlled through the incorporation of enzymatically degradable polymers.…”
Section: Carrier and Carrier Compositionmentioning
confidence: 99%